Molecular Partners Ag (MOLN) Goodwill & Intangibles (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Goodwill & Intangibles of $1.28 for Q1 2026, down 95.22% year-over-year from $26.69 in Q1 2025, and down 48.97% quarter-over-quarter from $2.5 in Q4 2025.
Molecular Partners Ag (MOLN) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Goodwill & Intangibles for 7 consecutive years, with $1.28 the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 95.22% year-over-year to $1.28; the TTM figure through Mar 2026 stood at $1.28 (down 95.22% YoY), while the FY2025 annual figure was $2.5, down 100.0% from the prior year.
- Goodwill & Intangibles slipped to $1.28 in Q1 2026 per MOLN's latest filing, from $2.5 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $2.6 million in Q4 2023 and bottomed at $1.28 in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $329040.9 across 5 years, with a median of $301.15 in 2023.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles climbed 17.51% — and 2025, when it sank 100.0%.
- Molecular Partners Ag's Goodwill & Intangibles stood at $2.2 million in 2022, then grew by 17.51% to $2.6 million in 2023, then plunged by 97.84% to $55934.6 in 2024, then tumbled by 100.0% to $2.5 in 2025, then slumped by 48.97% to $1.28 in 2026.
- Business Quant data shows MOLN's Goodwill & Intangibles at $1.28 in Q1 2026, $2.5 in Q4 2025, and $6.25 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 |
| Dec 31, 2025 | 2.50 |
| Sep 30, 2025 | 6.25 |
| Jun 30, 2025 | 12.08 |
| Mar 31, 2025 | 26.69 |
| Dec 31, 2024 | 55,934.57 |
| Sep 30, 2024 | 94.64 |
| Jun 30, 2024 | 134,906.81 |
| Mar 31, 2024 | 189.04 |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 301.15 |
| Jun 30, 2023 | 308,072.63 |
| Mar 31, 2023 | 310.29 |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 297.18 |
| Jun 30, 2022 | 302,143.26 |
| Mar 31, 2022 | 308.60 |
| Dec 31, 2021 | 2.06 Mn |
| Sep 30, 2021 | 288.62 |
| Dec 31, 2020 | 1.69 Mn |